Furthermore, elevated levels of DKK1 are associated with heightened expression of PD-L1, diminished T cell infiltration, and increased immune evasion, all of which play a role in the advancement and resistance to therapy in CRC [44]. Here, DKK1 is linked to colorectal carcinoma.